标题
Fibroblast Activation Protein Cleaves and Inactivates Fibroblast Growth Factor 21
作者
关键词
-
出版物
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 291, Issue 11, Pages 5986-5996
出版商
American Society for Biochemistry & Molecular Biology (ASBMB)
发表日期
2016-01-22
DOI
10.1074/jbc.m115.710582
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Circulating FGF21 proteolytic processing mediated by fibroblast activation protein
- (2015) E. Y. Zhen et al. BIOCHEMICAL JOURNAL
- Role of fibroblast growth factor 21 in the early stage of NASH induced by methionine- and choline-deficient diet
- (2015) Naoki Tanaka et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Pharmacokinetics and pharmacodynamics of PF-05231023, a novel long-acting FGF21 mimetic, in a first-in-human study
- (2015) Jennifer Q. Dong et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Immuno-PET and Immuno-SPECT of Rheumatoid Arthritis with Radiolabeled Anti-Fibroblast Activation Protein Antibody Correlates with Severity of Arthritis
- (2015) P. Laverman et al. JOURNAL OF NUCLEAR MEDICINE
- Glucocorticoids Regulate the Metabolic Hormone FGF21 in a Feed-Forward Loop
- (2015) Rucha Patel et al. MOLECULAR ENDOCRINOLOGY
- Tissue-specific actions of the metabolic hormones FGF15/19 and FGF21
- (2015) Bryn M. Owen et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Deficiency of fibroblast activation protein alpha ameliorates cartilage destruction in inflammatory destructive arthritis
- (2015) Stefan Wäldele et al. ARTHRITIS RESEARCH & THERAPY
- Serum FGF21 levels are associated with brown adipose tissue activity in humans
- (2015) Mark J.W. Hanssen et al. Scientific Reports
- A rare variant in human fibroblast activation protein associated with ER stress, loss of enzymatic function and loss of cell surface localisation
- (2014) Brenna Osborne et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Circulating FGF21 Is Liver Derived and Enhances Glucose Uptake During Refeeding and Overfeeding
- (2014) K. R. Markan et al. DIABETES
- Fibroblast growth factor 21 participates in adaptation to endoplasmic reticulum stress and attenuates obesity-induced hepatic metabolic stress
- (2014) Seong Hun Kim et al. DIABETOLOGIA
- Fibroblast Growth Factor 21 Limits Lipotoxicity by Promoting Hepatic Fatty Acid Activation in Mice on Methionine and Choline-Deficient Diets
- (2014) Ffolliott M. Fisher et al. GASTROENTEROLOGY
- Fibroblast Growth Factor 21 Is Regulated by the IRE1α-XBP1 Branch of the Unfolded Protein Response and Counteracts Endoplasmic Reticulum Stress-induced Hepatic Steatosis
- (2014) Shan Jiang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- FGF21 is an endocrine signal of protein restriction
- (2014) Thomas Laeger et al. JOURNAL OF CLINICAL INVESTIGATION
- Extended Structure–Activity Relationship and Pharmacokinetic Investigation of (4-Quinolinoyl)glycyl-2-cyanopyrrolidine Inhibitors of Fibroblast Activation Protein (FAP)
- (2014) Koen Jansen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013
- (2014) Marie Ng et al. LANCET
- Ectopic Fat in Insulin Resistance, Dyslipidemia, and Cardiometabolic Disease
- (2014) Gerald I. Shulman NEW ENGLAND JOURNAL OF MEDICINE
- Understanding fibroblast activation protein (FAP): Substrates, activities, expression and targeting for cancer therapy
- (2014) Elizabeth J. Hamson et al. Proteomics Clinical Applications
- FGF21-based pharmacotherapy – potential utility for metabolic disorders
- (2014) Ruth E. Gimeno et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Novel sandwich immunoassays for the measurement of total and active FGF21
- (2014) Tara S Umberger et al. Bioanalysis
- Adiponectin Mediates the Metabolic Effects of FGF21 on Glucose Homeostasis and Insulin Sensitivity in Mice
- (2013) Zhuofeng Lin et al. Cell Metabolism
- An FGF21-Adiponectin-Ceramide Axis Controls Energy Expenditure and Insulin Action in Mice
- (2013) William L. Holland et al. Cell Metabolism
- The Effects of LY2405319, an FGF21 Analog, in Obese Human Subjects with Type 2 Diabetes
- (2013) Gregory Gaich et al. Cell Metabolism
- MEROPS: the database of proteolytic enzymes, their substrates and inhibitors
- (2013) Neil D. Rawlings et al. NUCLEIC ACIDS RESEARCH
- Rational Design of a Fibroblast Growth Factor 21-Based Clinical Candidate, LY2405319
- (2013) Alexei Kharitonenkov et al. PLoS One
- Quantitation of fibroblast activation protein (FAP)-specific protease activity in mouse, baboon and human fluids and organs
- (2013) Fiona M. Keane et al. FEBS Open Bio
- Fibroblast activation protein
- (2012) Rui Liu et al. CANCER BIOLOGY & THERAPY
- Fibroblast Growth Factor 21 Predicts the Metabolic Syndrome and Type 2 Diabetes in Caucasians
- (2012) T. Bobbert et al. DIABETES CARE
- FGF21 regulates PGC-1 and browning of white adipose tissues in adaptive thermogenesis
- (2012) f. M. Fisher et al. GENES & DEVELOPMENT
- Long-Term Fenofibrate Therapy Increases Fibroblast Growth Factor 21 and Retinol-Binding Protein 4 in Subjects with Type 2 Diabetes
- (2012) Kwok Leung Ong et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Rationale-Based Engineering of a Potent Long-Acting FGF21 Analog for the Treatment of Type 2 Diabetes
- (2012) Randy Hecht et al. PLoS One
- Cleavage-site specificity of prolyl endopeptidase FAP investigated with a full-length protein substrate
- (2011) Chih-Hsiang Huang et al. JOURNAL OF BIOCHEMISTRY
- Enhancement of fibrinolysis by inhibiting enzymatic cleavage of precursor α2-antiplasmin: a rebuttal
- (2011) E. AGUSTÍ-COBOS et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Circulating Fibroblast Growth Factor 21 Levels Are Closely Associated with Hepatic Fat Content: A Cross-Sectional Study
- (2011) Hongmei Yan et al. PLoS One
- Amelioration of Type 2 Diabetes by Antibody-Mediated Activation of Fibroblast Growth Factor Receptor 1
- (2011) A.-L. Wu et al. Science Translational Medicine
- Dipeptidyl Peptidase-4 Inhibitors Administered in Combination With Metformin Result in an Additive Increase in the Plasma Concentration of Active GLP-1
- (2010) E M Migoya et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The dipeptidyl peptidase IV family in cancer and cell biology
- (2010) Denise M. T. Yu et al. FEBS Journal
- Different roles of N- and C- termini in the functional activity of FGF21
- (2009) Radmila Micanovic et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice
- (2009) Angélica M. Santos et al. JOURNAL OF CLINICAL INVESTIGATION
- The Circulating Metabolic Regulator FGF21 Is Induced by Prolonged Fasting and PPARα Activation in Man
- (2008) Cecilia Gälman et al. Cell Metabolism
- Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor-21 in patients with type 2 diabetes and obesity
- (2008) M. Mraz et al. CLINICAL ENDOCRINOLOGY
- Serum FGF21 Levels Are Increased in Obesity and Are Independently Associated With the Metabolic Syndrome in Humans
- (2008) X. Zhang et al. DIABETES
- Fibroblast Growth Factor 21 Reverses Hepatic Steatosis, Increases Energy Expenditure, and Improves Insulin Sensitivity in Diet-Induced Obese Mice
- (2008) J. Xu et al. DIABETES
- Fibroblast Growth Factor 21 Corrects Obesity in Mice
- (2008) Tamer Coskun et al. ENDOCRINOLOGY
- FGF21 N- and C-termini play different roles in receptor interaction and activation
- (2008) Junming Yie et al. FEBS LETTERS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now